GET LINCKR

Neuroplast Company Contacts

Neuroplast

https://www.neuroplast.com
Neuroplast is a clinical stage biotech that develops the stem cell product Neuro-Cells®, a first-in-kind treatment to combat neurodegenerative diseases, for which no effective treatment exists today. Neurodegenerative diseases will impact 115 million people worldwide by 2050. Spinal cord injury,... Read More
Contacts

Country

Netherlands

City

Geleen

Headquarters

Geleen, Limburg

LinkedIn

Profile

Founded

2014

Industry

Biotechnology

Size

11 - 50

Specialties

Stem cell technology, Neurodegenerative diseases, Regenerative medicine, Orphan diseases, Living medicine, Spinal cord injury, Frontotemporal dementia, Traumatic brain injury, ALS, MS, Parkinson's disease, Fast-track development programs, GMP - Good Manufacturing Practice, Neuro-Cells (r)

Funding

Total Rounds

2

Last Round

Tue Nov 16 2021

Last Round Series

Series B

Last Round Raised

$ 11,317,953